<?xml version="1.0" encoding="UTF-8" ?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">


<journal>
<language>en</language>
<journal_id_issn>1726-7536</journal_id_issn>
<journal_id_issn_online>1735-8507</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi></journal_id_doi>
<journal_id_isnet></journal_id_isnet>
<journal_id_iranmedex>69</journal_id_iranmedex>
<journal_id_magiran>2139</journal_id_magiran>
<journal_id_sid>288</journal_id_sid>
<pubdate PubStatus="epublish">
	<type>gregorian</type>
	<year>2024</year>
	<month>3</month>
	<day>18</day>
</pubdate>
<volume>25</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>39157278</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>Serum Testosterone-Estradiol Ratio in Toxoplasma-Seropositive Infertile Men: A Prospective, Single-Center Study</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: The purpose of the current study was to compare the testosterone-estradiol (T:E2) ratio in Toxoplasma gondii (T. gondii) seropositive infertile men with seropositive and seronegative normozoospermic controls.&lt;br /&gt;
Methods: A total of 200 men with normal virilization, including 100 with idiopathic infertility and 100 normozoospermic men, were included in the study. Participants underwent a comprehensive evaluation including a detailed medical history assessment, physical examination, semen analysis, testing for T. gondii IgM/IgG, and estimation of serum T:E2 ratios. Statistical comparisons between groups were performed using t-test and Chi square (x&lt;sup&gt;2&lt;/sup&gt;) with a significance level set at p&amp;lt;0.05.&lt;br /&gt;
Results: Infertile cases were diagnosed with oligozoospermia (63%), oligoasthenozoospermia (34%), and oligoasthenoteratozoospermia (3%). Regarding anti-Toxoplasma IgG and IgM antibodies, among infertile men, 34 tested positive for IgG and 8 tested positive for IgM. Among the 34 infertile men who tested positive for IgG antibodies, 13 individuals (38.2%) had disturbed T:E2 ratios. Also, among the 12 IgG-positive controls, 5 individuals (41.7%) had disturbed T:E2 ratios (p=0.834). However, only 2 out of the 83 seronegative controls (2.5%) had disturbed T:E2 ratios, which was statistically significant (p&amp;lt;0.001). Furthermore, 6 out of 8 IgM-positive infertile men had altered T:E2 ratios, compared to 3 out of 5 IgM-positive controls (p=0.568) and 2 out of 83 seronegative controls (p&amp;lt;0.001). The T:E2 ratio was significantly lower (8.68&amp;plusmn;1.95) among IgM-positive infertile men and higher (13.04&amp;plusmn;3.78) among IgG-positive infertile men when compared to seronegative controls (10.45&amp;plusmn;0.54) (p&amp;lt;0.001). There were no significant differences in the testosterone-estradiol (T:E2) ratios between infertile men with positive IgM or IgG serology and the control group with the same serology.&lt;br /&gt;
Conclusion: A significant proportion of infertile men with toxoplasmosis exhibit altered T:E2 ratios. These findings emphasize the importance of conducting anti-T. gondii-IgG testing in individuals with abnormal T:E2 ratios.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Asthenozoospermia, Estradiol, Immunoglobulin G, Immunoglobulin M, Male infertility, Oligospermia, Testosterone, Toxoplasma</keyword>
	<start_page>28</start_page>
	<end_page>38</end_page>
	<web_url>https://www.jri.ir/article/140217</web_url>
	<pdf_url>https://www.jri.ir/documents/fullpaper/en/140217.pdf</pdf_url>
	<author_list><author><first_name>Ahmed</first_name><middle_name></middle_name><last_name>Ragab</last_name><suffix></suffix><affiliation>Department of Andrology, Sexology and STIs, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email>drahmedragab1981@ gmail.com, ahmed.abdeltawab@ med.bsu.edu.eg</email><code>1296</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Doaa</first_name><middle_name></middle_name><last_name>Hamdy</last_name><suffix></suffix><affiliation>Department of Medical Parasitology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>122665</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Shimaa</first_name><middle_name></middle_name><last_name>Ibrahim</last_name><suffix></suffix><affiliation>Department of Medical Parasitology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>122666</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

